Odyssey Health (ODYY) Share-based Compensation Growth (1y) (2020 - 2025)
Odyssey Health (ODYY) Share-based Compensation Growth (1y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | 18.31% |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | -78.13% |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 6.74% |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 16.00% |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | 12.53% |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | -13.91% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 60.71% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 5.29% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 7.56% |
| 10 | Odyssey Health | 1.01 Mn | 711,880.61 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2025 | -77.12% |
| Jan 31, 2025 | -94.67% |
| Oct 31, 2024 | 3,356.40% |
| Jul 31, 2024 | 44.87% |
| Apr 30, 2024 | -91.40% |
| Jan 31, 2024 | 2.66% |
| Oct 31, 2023 | -99.85% |
| Jul 31, 2023 | 248.33% |
| Apr 30, 2023 | 39.06% |
| Jan 31, 2023 | 29.05% |
| Oct 31, 2022 | 119.22% |
| Jul 31, 2022 | -107.20% |
| Apr 30, 2022 | -74.83% |
| Jan 31, 2022 | 357.64% |
| Oct 31, 2021 | 309.20% |
| Jul 31, 2021 | 399.13% |
| Apr 30, 2021 | -16.38% |
| Jan 31, 2021 | -38.57% |
| Oct 31, 2020 | -87.57% |
| Jul 31, 2020 | 158.28% |